Prognosis for Treatment of Glioblastoma Multiforme Expected to Impact Market Growth for Drug Makers
Palm Beach, FL – March 3, 2020 – The global Glioblastoma multiforme (GBM) drugs market, is projected to reach nearly $1.4 billion by 2025, expanding at a CAGR of 12.6% during the forecast period, driven by rising geriatric population, growing incidence cases and rich clinical pipeline of new products. Glioblastoma is the most common primary malignant […]
The American Energy Innovation Act Could Be a Sizable Catalyst for Microgrids
Palm Beach, FL – March 3, 2020 — The U.S. Senate is set to vote this week on an energy package that could increase federal funding for a number of energy technologies, including microgrids. Known as The American Energy Innovation Act, introduced by Sens. Lisa Murkowski, R-Alaska, and Joe Manchin, D-West Virginia, who referred to […]
Box Office Boom: China is Still on Course to Dethrone the U.S.
Palm Beach, FL – March 3, 2020 — China is still on course to dethrone the U.S. as the top film market. In fact, according to Fortune, China has already overtaken the U.S. in terms of numbers of theaters following a build boom “that helped box-office sales climb six-fold since 2010.” Better, film ticket sales […]
Research Studies Progressing Towards New FDA Approved Treatments For Glioblastoma
Palm Beach, FL – March 3, 2020 – Although there is presently no cure for glioblastoma, researchers are continually inching closer to new and effective treatment options. Glioblastoma is a type of brain cancer that affects the astrocytes, which are a type of cell found in the brain and spinal cord. This form of cancer […]
CNS Pharmaceuticals Announces Brain Cancer Patient from Berubicin Phase 1 Trial Remains Cancer Free
Phase 2 Clinical Trials to Begin subject to FDA IND Approval Houston, TX – March 3, 2020 – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announces as of February 2020, […]
